MARKET

PTPI

PTPI

Petros Pharmaceuticals Inc
NASDAQ
0.1331
-0.0269
-16.81%
Pre Market: 0.1495 +0.0164 +12.32% 07:12 05/19 EDT
OPEN
0.1500
PREV CLOSE
0.1600
HIGH
0.1500
LOW
0.1320
VOLUME
6.11K
TURNOVER
--
52 WEEK HIGH
18.00
52 WEEK LOW
0.1010
MARKET CAP
4.15M
P/E (TTM)
-0.0016
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at PTPI last week (0512-0516)?
Weekly Report · 7h ago
Petros Pharmaceuticals, Inc. Reports Financial Results for the Quarter Ended March 31, 2025
Press release · 3d ago
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga · 4d ago
Weekly Report: what happened at PTPI last week (0505-0509)?
Weekly Report · 05/12 11:05
Petros Pharmaceuticals strengthens partnership with big data provider
TipRanks · 05/06 13:25
Weekly Report: what happened at PTPI last week (0428-0502)?
Weekly Report · 05/05 11:07
AI Daily: Microsoft reports earnings, says Cloud, AI ‘essential inputs’
TipRanks · 05/01 18:45
Petros Pharmaceuticals developing SaaS Platform using AI, EHR
TipRanks · 05/01 13:35
More
About PTPI
Petros Pharmaceuticals, Inc. is focused on the self-care market by providing expanded access to key prescription pharmaceuticals such as OTC treatment options. The Company is engaged in developing a software-as-a-service (SaaS) platform designed to assist pharmaceutical companies in meeting FDA standards to assist in the Rx-to-OTC switch. In addition to the SaaS component, the platform is intended to incorporate software as a medical device (SaMD) capabilities, transforming traditional OTC medications into digitally enabled solutions. The SaMD interface seeks to be designed as customized and branded to pharmaceutical therapy and established as a specific application pathway to that therapy. Together, it aims to develop the SaaS and SaMD components to create a scalable, licensable platform that supports various classes of medications across the pharmaceutical industry, assisting pharmaceutical companies achieve regulatory approval, while delivering consumer-focused healthcare solutions.

Webull offers Petros Pharmaceuticals Inc stock information, including NASDAQ: PTPI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PTPI stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PTPI stock methods without spending real money on the virtual paper trading platform.